[Dosing regimens of antibiotics in neonates: Variations in clinical practice and what should be done?]

Area of Science:

• Neonatal Pharmacology
• Pediatric Infectious Diseases
• Drug Development

Background:

• Significant variability exists in current neonatal antibiotic dosing practices, both domestically and internationally.
• Antibiotics are frequently prescribed to neonates, yet many lack comprehensive evaluation for this population.
• This variability highlights a critical gap in evidence-based guidelines for neonatal antimicrobial therapy.

Purpose of the Study:

• To address the need for optimized antibiotic prescription in neonates.
• To improve the efficacy and safety of antibiotic treatments in newborns.
• To mitigate the growing problem of antimicrobial resistance in neonatal populations.

Main Methods:

• Review of existing literature on neonatal antibiotic pharmacokinetics and pharmacodynamics.
• Analysis of current clinical practices in neonatal antibiotic prescribing.
• Identification of research needs for evidence-based regimen development.

Main Results:

• Current neonatal antibiotic dosing lacks standardization and robust evaluation.
• Developmental pharmacokinetics and pharmacodynamics are crucial for rational prescribing.
• There is a clear need for rigorous, collaborative studies to establish evidence-based guidelines.

Conclusions:

• Optimization of neonatal antibiotic use is essential for patient safety and combating resistance.
• Evidence-based neonatal dosage regimens require further research and validation.
• Collaboration between neonatologists and pharmacologists is key to advancing neonatal pharmacotherapy.